CIM Case: Metastatic Renal Cell Carcinoma to Humerus
Clinical Scenario
Patient: 58-year-old man
Presentation: Progressive left arm pain for 8 weeks, now with difficulty lifting objects, pain at night disturbing sleep
Relevant history: Renal cell carcinoma diagnosed 2 years ago (right nephrectomy, clear cell type, T3aN0M0 at diagnosis), recent surveillance CT showed no recurrence in renal bed, no prior chemotherapy, otherwise well, smoker (20 pack-years), no other medical history
Examination findings:
Well-appearing man, no cachexia
Tender mass palpable over mid-left humerus (firm, fixed to bone)
Overlying skin normal, warm to touch
Full shoulder and elbow range of motion (limited by pain)
No wasting of deltoid or arm muscles
Neurovascularly intact distally (radial pulse normal)
Lungs clear on auscultation
Abdomen soft, left nephrectomy scar healed
Investigations Provided
Laboratory Results
Test Result Normal Range Interpretation Hb 125 g/L 130-170 g/L ↓ Mildly low WCC 7.8 ×10⁹/L 4-11 ×10⁹/L Normal Platelets 245 ×10⁹/L 150-400 ×10⁹/L Normal CRP 12 mg/L <5 mg/L ↑ Mildly elevated ESR 35 mm/hr <20 mm/hr ↑ Elevated Calcium 2.75 mmol/L 2.2-2.6 mmol/L ↑ Elevated ALP 185 U/L 30-120 U/L ↑ Elevated Albumin 38 g/L 35-50 g/L Normal LDH 280 U/L 120-250 U/L ↑ Mildly elevated Creatinine 115 μmol/L 60-110 μmol/L ↑ Mildly elevated (single kidney) eGFR 58 mL/min >60 ↓ Stage 3 CKD
Imaging
Image 1: AP and Lateral Radiographs of Left Humerus
Radiological features:
Large lytic lesion in mid-diaphysis of humerus
Geographic destruction with moth-eaten margins
Cortical erosion (>50% circumference involved)
No matrix mineralisation
Soft tissue mass visible extending from bone
No periosteal reaction
No pathological fracture yet
Lesion spans approximately 8cm longitudinally
Image 2: CT Chest/Abdomen/Pelvis (Staging)
Findings:
Right nephrectomy (known)
No renal bed recurrence
No liver metastases
Solitary 5mm pulmonary nodule in right lower lobe (indeterminate)
No other bone lesions on CT
No lymphadenopathy
Image 3: Bone Scan (Whole Body)
Findings:
Hot lesion in mid-left humerus
Cold centre (photopenic) with hot rim
No other skeletal lesions
Normal uptake in kidneys/bladder
Questions & Model Answers
Q1
What is your differential diagnosis and most likely diagnosis?
Reveal Answer
Q2
What is the fracture risk and how would you assess it?
Reveal Answer
Q3
What is the staging workup and significance of the solitary metastasis?
Reveal Answer
Q4
What is the role of preoperative embolisation?
Reveal Answer
Q5
What are the surgical options for this lesion?
Reveal Answer
Q6
What is the prognosis and what systemic treatment options exist for metastatic RCC?
Reveal Answer
Key Teaching Points
Pattern Recognition
This pattern suggests Renal Cell Carcinoma Bone Metastasis:
History of RCC (even remote)
Lytic, expansile bone lesion
Hypercalcaemia
Hypervascular appearance on imaging
Hot lesion with cold centre on bone scan (vascular tumour necrosis)
Late presentation (years after primary)
Lytic Bone Metastases Mnemonic: "Lots of Trouble Kills Patients Badly":
L ung
T hyroid
K idney
P rostate (usually blastic, can be lytic)
B reast
Critical Management Points
Confirm solitary - PET-CT before planning curative surgery
Preoperative embolisation - ESSENTIAL for RCC (highly vascular)
Mirels score ≥9 - prophylactic fixation indicated
Wide excision for curative intent - if truly solitary, 2-3cm margins
MDT approach - oncology, orthopaedics, IR, radiology
Bone-modifying agents - reduce skeletal events
Long-term surveillance - RCC can recur late
Common Examiner Follow-ups
Q: "What is the 'cold in hot' sign on bone scan and what does it indicate?"
The "cold in hot" or "doughnut" sign:
Peripheral hot rim with central photopenic (cold) area
Indicates highly vascular tumour with central necrosis
Classic for renal cell carcinoma metastases
Also seen in aggressive vascular tumours
Mechanism: The centre has outgrown its blood supply leading to necrosis, while the periphery remains hypervascular and metabolically active.
Q: "Why is RCC relatively radioresistant and what are the implications?"
RCC is considered radioresistant because:
Conventional fractionated RT has limited efficacy
May relate to hypoxic tumour microenvironment
VHL pathway mutations affect hypoxia response
Implications:
Surgery preferred for local control when feasible
Stereotactic body radiotherapy (SBRT) more effective (high dose per fraction)
Radiotherapy alone not reliable for local control
Post-operative RT role is limited
Q: "How do you manage the 5mm lung nodule?"
Management of indeterminate lung nodule:
Repeat CT in 3-6 months (Fleischner Society guidelines)
If stable for 2 years: likely benign
If growing: biopsy or resection
PET-CT has limited sensitivity for lesions <8mm
Changes surgical plan if proven metastatic (no longer solitary)
For this patient:
If nodule is stable/benign: proceed with curative resection of humerus
If nodule is metastatic: palliative approach more appropriate
Q: "What are the indications for amputation in this scenario?"
Amputation indications for bone metastasis (rare):
Massive neurovascular involvement not reconstructable
Failed limb salvage with infection
Uncontrollable haemorrhage
Fungating tumour with skin breakdown
Patient preference after informed discussion
For this patient with localised disease, limb salvage should be achievable with modern techniques.
Pathological Fractures
Mirels Scoring System
Preoperative Embolisation
Endoprosthetic Reconstruction
Bone Metastasis Management
Immunotherapy in Oncology